|
⚲
|
| Keyboard |
| DBV Technologies Sa | |
|---|---|
| Ticker | DBVT |
| CIK # | 0001613780 |
| CUSIP | 23306J309 |
| Sector | Life Sciences - Biological Products, (No Disgnostic Substances) |
| Address | 177-181 Avenue Pierre Brossolette, Montrouge, 92120 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| DBV Technologies Sa | 2025-04-17 | 306.9 M | Exemption: 506(b) · Duration: One year or less · Commission: $18,414,000 · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001613780] | 10-K | |
| [0001613780] | 10-Q | |
| [0001613780] | 3 | |
| [0001613780] | 4 | |
| [0001613780] | 6-K | |
| [0001613780] | 8-K | |
| [0001613780] | D | |
| [0001613780] | SC 13D | |
| [0001613780] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Mohideen Pharis
Ordinary Shares
|
2026-01-29 | Sell | 534 | $4.86 | 2,595 |
|
Baker Brothers Life Sciences LP +5
BS Warrant · derivative
|
2026-01-12 | Option exercise | 25,005,240 | $0.00 | |
|
Baker Brothers Life Sciences LP +5
Second Pre-Funded Warrant · derivative
|
2026-01-12 | Option exercise | 2,299,656 | $0.00 | |
|
Baker Brothers Life Sciences LP +5
BS Warrant · derivative
|
2026-01-12 | Option exercise | 2,299,656 | $0.00 | |
|
Baker Brothers Life Sciences LP +5
Second Pre-Funded Warrant · derivative
|
2026-01-12 | Option exercise | 25,005,240 | $0.00 | |
|
Bpifrance SA +4
Ordinary Shares
|
2025-12-18 | Sell | 1,292,103 | $4.19 | 5,413,912 |
|
Bpifrance SA +4
Ordinary Shares
|
2025-12-17 | Sell | 40,000 | $5.28 | 211,200 |
|
Bpifrance SA +4
Ordinary Shares
|
2025-12-17 | Sell | 2,036,990 | $4.84 | 9,859,032 |
|
Tasse Daniel
Employee Stock Option (right to buy) · derivative
|
2025-11-21 | Grant | 964,000 | $0.00 | |
|
Mohideen Pharis
Ordinary Shares
|
2025-11-21 | Sell | 1,624 | $2.77 | 4,498 |
|
Mohideen Pharis
Ordinary Shares
|
2025-11-21 | Grant | 44,000 | $0.00 | |
|
Boucinha Virginie
Ordinary Shares
|
2025-11-21 | Grant | 32,000 | $0.00 | |
|
Trapp Kevin Michael
Ordinary Shares
|
2025-11-21 | Grant | 55,000 | $0.00 | |
|
Mohideen Pharis
Employee Stock Option (right to buy) · derivative
|
2025-11-21 | Grant | 253,000 | $0.00 | |
|
Boucinha Virginie
Employee Stock Option (right to buy) · derivative
|
2025-11-21 | Grant | 192,000 | $0.00 | |
|
Trapp Kevin Michael
Employee Stock Option (right to buy) · derivative
|
2025-11-21 | Grant | 316,250 | $0.00 | |
|
Mohideen Pharis
Ordinary Shares
|
2025-11-20 | Sell | 6,496 | $2.88 | 18,708 |
|
Mohideen Pharis
Ordinary Shares
|
2025-07-29 | Sell | 464 | $2.22 | 1,030 |
|
Mohideen Pharis
Ordinary Shares
|
2025-05-22 | Sell | 397 | $1.84 | 730 |
|
Baker Brothers Life Sciences LP +5
BS Warrant · derivative
|
2025-03-27 | Grant | 2,299,656 | ||
| showing 20 of 69 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 72 | 21,160,080 |
| 2025-12-31 | 52 | 16,176,096 |
| 2025-09-30 | 33 | 6,519,308 |
| 2025-06-30 | 29 | 7,232,630 |
| 2025-03-31 | 18 | 2,467,962 |
| 2024-12-31 | 19 | 2,737,085 |
| 2024-06-30 | 2 | 250,117 |
| 2024-03-31 | 34 | 38,943,357 |
| 2023-12-31 | 41 | 38,361,333 |
| 2023-09-30 | 39 | 44,389,362 |
| 2023-06-30 | 37 | 46,014,604 |
| 2023-03-31 | 35 | 42,240,414 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Burns Matteson Capital Management LLC | [2026-06-30] | SOLE | 21,818 | 21,818 |
| Gamma Investing LLC | [2026-06-30] | DFND | 2,832 | 2,832 |
| HM Payson & Co | [2026-06-30] | OTR | 0 | 420 |
| Farther Finance Advisors LLC | [2026-06-30] | SOLE | 0 | 164 |
| Trust Co of Toledo NA /OH/ | [2026-06-30] | SOLE | 10 | 10 | Prev | Page 1 | Next |